NeuroPace (NASDAQ: NPCE)
NeuroPace Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NeuroPace Company Info
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
Valuation
Earnings Transcripts
NeuroPace, Inc. (NPCE) Q2 2022 Earnings Call Transcript
NPCE earnings call for the period ending June 30, 2022.
NeuroPace, Inc. (NPCE) Q1 2022 Earnings Call Transcript
NPCE earnings call for the period ending March 31, 2022.
NeuroPace, Inc. (NPCE) Q4 2021 Earnings Call Transcript
NPCE earnings call for the period ending December 31, 2021.
NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript
NPCE earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.